Sarclisa recommended for EU approval by the CHMP to treat transplant-ineligible newly diagnosed multiple myelomaRecommendation based on IMROZ ...
Zoomcar Holdings, Inc. ('Zoomcar,' or 'we,' or 'our'), the leading marketplace for car sharing in India, today announced results for its second quarter ended September 30, 2024. Hiroshi Nishijima, ...
Healx will use its AI-based drug discovery tech to analyze proprietary Sanofi compound data and identify potential rare disease targets.
DelveInsight's 'Multiple Sclerosis Pipeline Insight 2024' report provides comprehensive global coverage of pipeline multiple ...
From the company's own site, we can see this pharma brand has a diversified portfolio of therapies across multiple clinical ...
The importance of early-stage CMC de-risking Dan Jacobs discussed his experience at Pioneering Medicines, where the company ...
TORK US on MSN1d
This is how Audi was born: the origin of its iconic four ringsThis is the origin of the Audi logo, a symbol full of globalization, a design available to any mortal, easy to reproduce by ...
MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...
Further boosting the pipeline, mid-stage drugs like Sanofi/Regeneron’s itepekimab, AstraZeneca’s benralizumab, Amgen Inc ...
“The development of Muse, a result of our ongoing collaboration with OpenAI and Formation Bio, represents another proof point ...
The firm owned 44,289 shares of the company’s stock after acquiring an additional 8,494 shares during the quarter. Crossmark ...
The partnership also allows Sanofi to use the company's adjuvant, Matrix-M ... One-trick pony? The Novavax logo displayed on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback